North America PARP Inhibitors Market Gains Momentum Through Precision Oncology Research
The global PARP inhibitors market is projected to grow from USD 7.4 billion in 2026 to USD 17.0 billion by 2036, registering a compound annual growth rate (CAGR) of 8.7%, according to Future Market Insights (FMI). The market is expected to add USD 9.6 billion in revenue over the forecast period as precision oncology expands, genetic testing identifies more eligible patients, and targeted...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek